← Back to screener

CHEMED CORP CHE

Rank #728 · NYSE · $7.1B market cap
Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.
Score
59.7
P/E
26.0
P/B
8.89
ROE
34.1%
Op. Margin
15.0%
Debt Ratio
69%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E 26.0x, P/B 8.89x. Ranks in the top 57% of the universe.

Profitability ★★★★☆
Excellent

ROE 34.1%. Ranks in the top 20% of the universe.

Safety ★★★★☆
Good

Debt ratio 69%. Ranks in the top 29% of the universe.

Growth ★★★☆☆
Average

Revenue growth of 6.1% year over year. Ranks in the top 46% of the universe.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$0.1B$0.1B$0.5B–80
2012–$0.1B$0.1B$0.4B–92
2013–$0.2B$0.1B$0.5B–90
2014–$0.2B$0.1B$0.4B–99
2015–$0.1B$0.1B$0.5B–90
2016–$0.2B$0.1B$0.4B–76
2017–$0.2B$0.1B$0.5B–79
2018$1.6B$0.2B$0.1B$0.5B11.374
2019$1.7B$0.1B$0.1B$0.5B6.873
2020$1.8B$0.2B$0.2B$0.5B13.7100
2021$1.9B$0.3B$0.2B$0.6B13.390
2022$2.1B$0.4B$0.3B$0.7B18.799
2023$2.1B$0.3B$0.3B$0.9B16.071
2024$2.1B$0.3B$0.2B$0.6B16.190
2025$2.3B$0.3B$0.3B$0.8B15.069

← See the full screener